Physicians Payment Sunshine Act: Strategies for Dispute Resolution…
The CBI Compliance Congress offered insight into how industry has approached Sunshine Act reporting. The presentation "Strategies…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
OPDP Offers Insight into Enforcement Strategy and Warning Letters
As part of CBI's Pharmaceutical Compliance Congress, Tom Abrams, director of the Food and Drug Administration's (FDA) Office of…
AMA Urges Court to Uphold Injunction Barring Medicare Advantage…
The American Medical Association (AMA) strongly opposes United HealthCare's (United) plan to drop Medicare Advantage providers.…
Non CME Strategies a Possible Adjunct to CME Activities
The Accreditation Council for Continuing Medical Education (ACCME) requires Continuing Medical Education (CME) providers to…
Pharmaceutical and Device Healthcare Fraud: Enforcement Perspectives for…
CBI's Pharmaceutical Compliance Congress started off both mornings of their two day conference with a matter sure to get…
International Organizations Announce Consensus Framework for Ethical…
Recently, five global health organizations - the International Alliance of Patients' Organizations (IAPO), International…
ACCME: Comments on Proposed Logo Ban Due to ACCME This Friday, January 31,…
The ACCME recently issued a Call for Comment regarding its proposal to eliminate the use of corporate logos from all CME…
HHS-OIG: Listing of Pharmaceutical and Device Corporate Integrity…
In addition to analysis of major settlements and corporate integrity agreements, each year we update the listing of important…
2013 IACE Survey Reveals CME Benchmarking Insights
The Industry Alliance for Continuing Education's (IACE) Benchmark Work Group (BWG) have shared their 2013 study of the…
FDA Three Draft Guidances To Regulate Compound Pharmacies – Registration,…
In November of 2013, President Obama signed into law the Drug Quality and Security Act. Recently, with the agency's clarified…